Dominari HoldingsDOMH
About: Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
Employees: 29
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.22% more ownership
Funds ownership: 7.3% [Q3] → 7.53% (+0.22%) [Q4]
0% more funds holding
Funds holding: 15 [Q3] → 15 (+0) [Q4]
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
44% less capital invested
Capital invested by funds: $849K [Q3] → $474K (-$375K) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for DOMH.
Financial journalist opinion
Based on 3 articles about DOMH published over the past 30 days









